Skip to main content
. 2010 Jun 1;105(10):2218–2227. doi: 10.1038/ajg.2010.218

Table 6. Reasons for discontinuation of treatment.

  VSL#3 number of patients (%) Placebo number of patients (%)
Lack of efficacy 0 (0.0) 5 (6.8)
Clinical episode 0 (0.0) 0 (0.0)
Abnormal laboratory result 0 (0.0) 0 (0.0)
Death 0 (0.0) 0 (0.0)
Protocol violation 2 (1.4) 0 (0.0)
Lost to follow-up 3 (4.2) 1 (1.4)
Protocol interim criteria not met 0 (0.0) 0 (0.0)
Patient's consent withdrawn 2 (2.8) 1 (1.4)